Tadashi Kamei

Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial

William W. Busse, Eugene R. Bleecker, J Mark FitzGerald et al. · The Lancet Respiratory Medicine · 2018 · 298 citations

Asthma, Rheumatology, Extension Trial +10

Localization of S-100 protein and glial fibrillary acidic protein-related antigen in pleomorphic adenoma of the salivary glands.

Yuichi NAKAZATO, Junko Ishizeki, Kei Takahashi et al. · PubMed · 1982 · 208 citations

Elevation of Anti-Cytokeratin 18 Antibody and Circulating Cytokeratin 18: Anti-Cytokeratin 18 Antibody Immune Complexes in Sera of Patients with Idiopathic Pulmonary Fibrosis

N. Dobashi, Jiro Fujita, Makiko Murota et al. · Lung · 2000 · 65 citations

Fibrosis, Antifibrotic Therapy, Autoimmune Disease +9

Heterogeneous point mutations of the p53 gene in pulmonary fibrosis

Satoko Hojo, Jiro Fujita, Ichiro Yamadori et al. · European Respiratory Journal · 1998 · 55 citations · Full text

Fibrosis, Point Mutations, P53 Gene +11

Clinical features of non-specific interstitial pneumonia

Jiro Fujita, Ichiro Yamadori, Ichizo Suemitsu et al. · Respiratory Medicine · 1999 · 53 citations

Advanced Lung Disease, Respiratory Diseases, Clinical Features +2